BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36178114)

  • 1. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate.
    Mirchandani Y; Patravale VB; Brijesh S
    Nanomedicine (Lond); 2022 Jul; 17(16):1099-1114. PubMed ID: 36178114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhein methotrexate-decorated solid lipid nanoparticles altering adjuvant arthritis progression through endoplasmic reticulum stress-mediated apoptosis.
    El-Refaie WM; Ghazy MS; Ateyya FA; Sheta E; Shafek MY; Ibrahim MS; Ismail MM; Gowayed MA
    Inflammopharmacology; 2023 Dec; 31(6):3127-3142. PubMed ID: 37526838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
    Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
    J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of co-treatment with pioglitazone and methotrexate on experimentally induced rheumatoid arthritis in Wistar albino rats.
    Roy T; Banerjee I; Ghosh S; Dhali RS; De Pati A; Tripathi SK
    Indian J Pharmacol; 2017; 49(2):168-175. PubMed ID: 28706330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy.
    Zhou M; Hou J; Zhong Z; Hao N; Lin Y; Li C
    Drug Deliv; 2018 Nov; 25(1):716-722. PubMed ID: 29516758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Ramucirumab and methotrexate co-therapy in rheumatoid arthritis experimental model: Involvement of angiogenic and immunomodulatory signaling.
    Abdel-Maged AE; Gad AM; Wahdan SA; Azab SS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114702. PubMed ID: 31398424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freund's adjuvant induced arthritis with reduced hepatotoxicity.
    Li F; Li H; Luo S; Ran Y; Xie X; Wang Y; Zheng M; Wang M; Zhao Z; Li X
    Biomed Pharmacother; 2018 Oct; 106():637-645. PubMed ID: 29990853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
    Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
    Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of ginsenoside compound K and methotrexate was efficient in elimination of anaemia and reduction of disease activity in adjuvant-induced arthritis rats.
    Chen J; Wang W; Jiang M; Yang M; Wei W
    Pharm Biol; 2020 Dec; 58(1):1131-1139. PubMed ID: 33198544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Delivery of Aceclofenac and Methotrexate Nanoparticles Presents an Effective Treatment for Rheumatoid Arthritis.
    Negi S; Tandel N; Garg NK; Sharma P; Kumar R; Sharma P; Kumar R; Saini S; Sharma A; Tyagi RK
    Int J Nanomedicine; 2024; 19():2149-2177. PubMed ID: 38482519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-treatment of Nimbolide augmented the anti-arthritic effects of methotrexate while protecting against organ toxicities.
    Anchi P; Panda B; Mahajan RB; Godugu C
    Life Sci; 2022 Apr; 295():120372. PubMed ID: 35143824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity.
    Hasan H; Ismail H; El-Orfali Y; Khawaja G
    BMC Complement Altern Med; 2018 Dec; 18(1):337. PubMed ID: 30567538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemical and In-Vivo Anti-Arthritic Significance of
    Kamal RM; Sabry MM; Aly ZY; Hifnawy MS
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34203991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
    Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
    Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils.
    Lyu J; Wang L; Bai X; Du X; Wei J; Wang J; Lin Y; Chen Z; Liu Z; Wu J; Zhong Z
    ACS Appl Mater Interfaces; 2021 Jan; 13(1):266-276. PubMed ID: 33379867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
    Pandey S; Rai N; Mahtab A; Mittal D; Ahmad FJ; Sandal N; Neupane YR; Verma AK; Talegaonkar S
    Int J Biol Macromol; 2021 Feb; 171():502-513. PubMed ID: 33422513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate (MTX)-cIBR conjugate for targeting MTX to leukocytes: conjugate stability and in vivo efficacy in suppressing rheumatoid arthritis.
    Majumdar S; Anderson ME; Xu CR; Yakovleva TV; Gu LC; Malefyt TR; Siahaan TJ
    J Pharm Sci; 2012 Sep; 101(9):3275-91. PubMed ID: 22539217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats.
    Nirbhavane P; Sharma G; Singh B; Khuller GK; Goni VG; Patil AB; Katare OP
    AAPS PharmSciTech; 2018 Oct; 19(7):3187-3198. PubMed ID: 30143947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.